Memory

Long-term supplementation with spermidine improved neither memory function nor biomarkers compared with placebo in older adults with subjective cognitive decline, according to results of a clinical trial published in JAMA Network Open.

Large amounts of tau proteins in the brain affected memory function only when amyloid protein burden was also high in those with Alzheimer’s disease, data suggests in a study published in Brain.

Greater improvement in air quality was associated with slower cognitive decline in older, community-dwelling women, according to a longitudinal study in PLoS Medicine.

Rapid intensive care, including endovascular therapy after stroke, proved to be a factor in less memory loss, according to results of a survey published in the American Academy of Neurology.

Depression appeared to adversely affect cognitive performance but not cognitive change among a cohort of individuals aged 90 years or older, according to study results presented at the Alzheimer’s Association International Conference.

Older adults who received antihypertensive drugs that crossed the blood-brain barrier demonstrated improved memory recall compared with those who received other types of antihypertensive drugs, according to new results.

Masitinib, an oral tyrosine kinase inhibitor, improved measures of cognition, memory and activities of daily living in a phase 2b/3 study of patients with mild and moderate Alzheimer’s disease, according to a press release.

Late-life air pollution exposure among women aged 80 years or older appeared associated with increased risk for depressive episodes and episodic memory declines, according to study results published in Journal of the American Geriatrics Society.

Over-the-counter dietary supplements that claim to improve mental focus and memory contain unapproved drugs, according to research published in Neurology, the medical journal of the American Academy of Neurology.

Emotional memory reactivation before electroconvulsive therapy for depression did not offer significant benefits vs. control memory reactivation, according to results of a randomized clinical trial published in JAMA Network Open.